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ABSTRACT
In recent years, artificial intelligence (AI) technologies have greatly advanced and become a 
reality in many areas of our daily lives. In the health care field, numerous efforts are being 
made to implement the AI technology for practical medical treatments. With the rapid 
developments in machine learning algorithms and improvements in hardware performances, 
the AI technology is expected to play an important role in effectively analyzing and utilizing 
extensive amounts of health and medical data. However, the AI technology has various unique 
characteristics that are different from the existing health care technologies. Subsequently, 
there are a number of areas that need to be supplemented within the current health care 
system for the AI to be utilized more effectively and frequently in health care. In addition, 
the number of medical practitioners and public that accept AI in the health care is still low; 
moreover, there are various concerns regarding the safety and reliability of AI technology 
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implementations. Therefore, this paper aims to introduce the current research and application 
status of AI technology in health care and discuss the issues that need to be resolved.
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INTRODUCTION
Continuous developments in artificial intelligence (AI) technologies are expected to bring 
innovations to the future of health care. Machine learning, a subfield of AI, is the study 
of computer algorithm that is automatically improved through experience by applying 
mathematical approaches.1 Deep learning, a subset of machine learning, refers to an 
algorithm that learns by processing input data through artificial neural networks that mimic 
neurons in the biologic brain.2 The explosive growth of digital data, expansion of computing 
power fueled by innovation in hardware technologies, such as graphics processing unit, and 
rapid developments in machine learning algorithms, popularly implemented using deep 
learning, are all leaving a significant mark in the health care field. Accordingly, numerous 
medical journals have already published vast number of studies analyzing massive amounts of 
health data by using machine learning technology to diagnose and treat patients.3,4 Further, 
various studies have shown that applying AI in health care gives better results compared with 
the existing technologies. Some of these studies include analyzing medical images with AI 
technology to discriminate images and use them for treatments; predicting the course of a 
disease through various medical and health care data; developing medical devices that can 
support decision-making during treatments or for diagnosis; and encrypting medical data.5-11
Further, various attempts have been made to develop and commercialize AI-based medical 
devices. In addition to the top medical device manufacturers, such as General Electric, 
Siemens, and Phillips, leading global information technology (IT) companies, such as 
Samsung, Google, Apple Microsoft, and Amazon, and numerous competitive startups have 
demonstrated significant research achievements in the use of AI in health care. Based on 
these research achievements, the companies are working to establish business achievements 
as well. Additionally, these efforts made by the industry and medical field are contributing to 
the successful approval of AI-based medical devices by regulatory agencies. In the U.S., the 
Food and Drug Administration (FDA) approved the use of AI-based medical devices for the 
first time in 2017, and in Korea, the Ministry of Food and Drug Safety has approved the use of 
AI-based medical devices since 2018.
However, there are still many concerns regarding AI-based medical technology owing to how 
different AI-based health care technologies are from traditional health care technologies; 
thus, the number of actual clinical treatment implementations using AI is still limited.12,13 
To introduce and implement the AI technology in the actual medical site and to provide 
meaningful outcomes to the people involved in health care, including doctors and patients, 
various challenges need to be addressed. Therefore, this study discusses the status of the 
current developments in domestic and foreign AI technology in health care and examines the 
issues that need to be resolved to implement AI in health care.
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AI APPLICATION AREAS IN HEALTH CARE
Unlike the typical technologies that deal with physical realms, AI technology is breaking new 
ground, as it has implications in more psychological realms such as experience, intelligence, 
and judgment of the experts. In particular, since the drastic improvement in the performance 
of machine learning algorithms for pattern recognition with the introduction of deep 
learning technology, the ability of AI technology in analyzing data patterns has become 
similar to that of an average human ability for specific tasks (e.g., image recognition and 
speech recognition).14 As deep learning algorithms are based on artificial neural network 
resembling the network of neurons in the human brain and can learn very complex non-
linear relationships, they are being actively used in the tasks dealing with medical data.15 
Accordingly, a number of studies on the use of AI-based technologies in health care are 
currently being conducted (Table 1).
Medical image analysis
In addition to radiology, the use of machine learning algorithms in medical image analysis 
has been expanded widely to most medical departments that use images for fields such 
as pathology, dermatology, cardiology, gastroenterology, and ophthalmology. In detail, 
machine learning algorithms use computed tomography (CT), magnetic resonance imaging, 
ultrasound, pathology image, fundus image, and endoscope data to diagnose or classify the 
severity of the disease.8,16-22 When the machine learning algorithm was applied to the real-
time colonoscopy, the accuracy of the diagnosis was 94% and the negative predictive value 
was 96% in analyzing 466 tiny polyps.23,24 Among the many deep learning algorithms, the 
convolutional neural network algorithm, which retains high performance in image pattern 
analysis, has proven to be beneficial in analyzing medical images with complex patterns.4,25
In the medical industry, Siemens Healthineers has developed AI-based AI-Rad Companion 
Chest CT software to assist chest CT diagnosis26, and GE Healthcare is also working on the 
development of AI-based medical image analysis technology. Further, Philips Healthcare has 
developed IntelliSpace Discovery, an open platform for AI development and deployment,27 and 
is working to commercialize its IntelliSite Pathology Solution in the digital pathology diagnosis 
field.27 Arterys has received FDA clearance on its Cardio AI, Liver AI, and Lung AI software to 
establish Medical Imaging Cloud AI platform.28 Apart from the abovementioned examples, 
various companies, such as Zebra Medical Vison and Aidoc, are working to commercialize 
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Table 1. Current applications of artificial intelligence in health care
Technology Application scheme Application area
Robotics Provide high-quality treatment by improving the precision and accuracy of the surgical procedures. Medical device, Health IT
Digital secretary Find the golden hour of appropriate intervention by continuously monitoring the patient condition 
indicators and alerting the nurse when necessary.
Medical device, Health IT
Machine learning Predict and analyze patterns based on the data affecting treatment results. Reduce the uncertainty 
in the medical treatment decision-making by processing large volumes of diagnostic medical 
images through self-learning.
Diagnostic medical image, 
Health IT
Image processing Quickly process large amounts of medical images and apply the findings in judging the disease type 
and negative and positive test results.
Diagnostic medical image, 
Health IT
Natural language processing Convert long unstructured text data, such as medical charts, to be easily read and interpreted. Medical device, Health IT
Voice recognition Capture patient voice and language and store important information in electronic medical records. Medical device, Health IT
Statistical analysis Predict patient treatment results through rapidly analyzing large amounts of patient health record 
data.
Medicine, Health IT
Big data analysis Provide personalized recommendations to the patients and therapeutics by processing large 
amounts of data maintained by healthcare institutions.
Medicine, Health IT
Predictive modeling Predict treatment outcomes, such as predicting risky diseases, by applying mathematical models. Medicine, Health IT
IT = information technology.
AI-based medical image analysis tools. In Korea, a number of startups such as Vuno, Lunit, 
JLK Inspection, and Deepnoid are in the process of commercializing AI-based medical image 
analysis systems by receiving approval from the Ministry of Food and Drug Safety.
Smart IoT devices, signal, and in-vitro diagnostic analysis
Various technology giants such as IBM, Google, Apple, and Samsung are competing to 
develop and commercialize devices and services that can assist in improving the user health 
by acquiring health information from daily life using a combination of Internet of Things 
(IoT) technologies and wearable devices. In 2017, Apple installed a deep learning algorithm 
that detects atrial fibrillation on their smartwatch and received FDA approval.23 Using the 
photoplethysmography and accelerometer sensors, it learns the user's usual heart rates at 
rest and at activity, and sends a warning sign if there is a significant difference from the 
expected values. The deep learning algorithm also shows excellent accuracy in analyzing 
electrocardiogram (ECG). In a recent study, 91,232 single-lead ECGs were analyzed using 
a deep learning algorithm and showed high diagnostic performance similar to those of 
cardiologists.29 Applying the ECG pattern analysis algorithm to smart devices would be 
especially useful for patients with cardiovascular disease or chronic kidney disease with high 
blood potassium levels.
Global companies are developing other innovative medical devices as well, including non-
invasive glucose meters.30,31 Such bio-signal monitoring devices can be used for disease 
management and treatment in different hospital environments, such as intensive care 
unit, operating room, emergency room, and recovery room, in addition to being used for 
predicting and diagnosing diseases based on the accumulated real-time information. One 
prime example of this is the collaboration between Medtronic and IBM in developing Sugar.
IQ by combining Medtronic's continuous glucose monitoring and IBM's AI Watson.32 
The Sugar.IQ has been proven to directly help diabetic patients by reducing the number 
of hypoglycemia and hyperglycemia symptoms.33 In addition, PhysiQ's pinpointIQ 
device, which recently received the FDA approval, helps in preparing for sudden and fatal 
situations by continuously measuring the patient conditions from the wearable biosensors 
and by detecting subtle changes in the conditions.34 Philips has also commercialized its 
Connected Care Solutions, which is an IT solution that enables the medical staff to monitor 
the patient conditions from anywhere including the emergency room, recovery room, and 
nurses station, through tablet PCs and smartphones.35 Meanwhile, findings from studies 
that reported improvement in diagnosis sensitivity and specificity by applying machine 
learning to the multi-biomarker analysis have been used in real-world cases to classify the 
cancer-related biomarkers; moreover, machine learning has been applied in cases of in-vitro 
diagnosis of diseases such as tuberculosis and dementia.36-39
AI using electronic medical records (EMRs)
Currently, various attempts are actively being made to develop AI systems using EMRs. In the 
U.S., EMR companies including Allscripts, Athenahealth, Cerner, eClinicalWorks, and Epic 
are conducting research on optimizing hospital treatment processes using AI technology.40 
In Korea, EvidNet is working to develop multi-hospital clinical big data analysis technology 
based on observational health data sciences and informatics and common data model 
(CDM).41,42 Further, IBM has developed Watson for Oncology, which provides optimal 
personalized treatments for cancer patients, and its clinical trials are underway.43 As for the 
Korean companies, Selvas AI and Linewalks are conducting similar studies.
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CURRENT ISSUES OF AI IN HEALTH CARE
Issues of utilizing health care data
In most cases, health care data typically include personal identification information such 
as personal code, number, text, voice, sound, and image. To create a data-driven AI medical 
device, a large amount of these data carrying sensitive personal information are required, but 
obtaining such sensitive information may lead to legal issues regarding personal privacy.44-46 
The widespread use of wireless AI devices in health care requires a new technologies 
such as IoT and cloud computing, which enables to deal with the processing and storage 
limitations in such devices.47 However, cloud-assisted AI devices can give rise to serious 
security concerns to the private health care data. To solve this issue, technical research and 
attempts to change laws and regulations are in progress. In terms of technical research, 
various encryption technologies and de-identification or anonymization technologies of 
removing identity information are being developed. A popular example is the CDM-based 
distributed research network, which has recently received considerable attention in Korea.48 
Furthermore, a number of privacy-preserving data mining technologies such as the federated 
learning and homomorphic encryption have been developed in the U.S.49,50
Many countries worldwide are currently forming institutional and legal systems to address 
the conflicting interests between the use of health care information and the protection of 
personal information. In the U.S., the Health Insurance Portability and Accountability Act 
(HIPAA) established in 1996 has given individuals the data rights for medical information 
copies, and the Blue Button system has been established to allow individuals to diversify 
the use of data through viewing their own personal health records online. According to the 
HIPAA guidelines, anonymization on 18 identifiers of protected health information has 
been established to efficiently facilitate the use of health data.51 In addition, through the 
enactment of the Health Information Technology for Economic and Clinical Health Act 
(HITECH Act) in 2009, an electronic health record has been developed and promoted to 
increase the interoperability of medical information between hospitals.52 Furthermore, the 
Centers for Medicare & Medicaid has launched the MyHealthEData and Blue Button 2.0 
services in 2018 to enable patients to access and control their medical records and other 
health data. In Europe, through the General Data Protection Regulation established in 2016, 
the basic individual rights for personal information have been reinforced by mandating the 
EU members to protect personal information in accordance with the six data protection 
principles.53 In Korea, efforts have been made in recent years to promote research on big data 
by providing rights to collect and use health care data based on the revision of the Bioethics 
and Safety Act. However, despite these efforts from many countries, no country has been able 
to systematically resolve the privacy issues regarding health care data.
Regulatory affairs and policies for new devices
Most AI-based medical devices exist in the form of software, and they are generally new 
devices different from the traditional devices in terms of regulatory affairs. Hence, new 
policies need to be established to approve and regulate such devices. The International 
Medical Device Regulators Forum has categorized these AI software intended to be used for 
medical purposes as “Software as a Medical Device (SaMD)”.54 In the U.S., the Digital Health 
Unit was established by the FDA's Center for Devices and Radiological Health in May 2017 to 
promote the expertise in digital health care device approvals and regulations, and the FDA 
has announced the guidelines for SaMD in December 2017.55 The FDA acknowledges that the 
current regulations for traditional medical devices are not suitable for SaMDs that are faster 
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in development and modification.56 FDA has recently developed a Software Precertification 
Program, which enables faster marketing of SaMD through a developer-centered certification 
pathway unlike the existing pathway centered on individual products. Manufacturers who 
achieved ‘organizational excellence’ in this pathway can obtain exemption from premarket 
review for low-risk products. Japan, in accordance with the AI medical development plans 
announced in 2018, is planning to create comprehensive rules governing the use of AI in 
medical devices to minimize the existing AI medical device–related disputes and prevent the 
resulting R&D hinderances.57 Lastly in Korea, the “Approval and Review Guidelines for Big 
Data and AI-based Medical Devices” and “Review Guidelines for Clinical Effectiveness of 
AI-based Medical Devices” were announced in 2017, making them some of the first AI-related 
approval guidelines in the world.58 However, the standardized review index for the safety and 
effectiveness of the AI-based medical devices is still lacking worldwide.4
Safety and liability issues
The report on AI published by the U.S. National Science and Technology Council emphasizes 
on the fairness and safety to prevent any discrimination or failure and to prevent AI from 
causing unintended consequences (Fig. 1).59,60 For example, if the AI is developed to have a 
bias toward a specific population group, a mismanagement could occur in the prevention or 
diagnosis of a disease and thus discrimination could arise in which a specific population group 
is excluded from benefits. To address this, the federal government is promoting verification 
of the effectiveness and fairness of AI through the evidence-based assessment, and the federal 
government funding for research is mandated to be allocated based on the transparency, 
effectiveness, and fairness. Furthermore, the government is recommending the universities 
and secondary schools to include topics related to ethics, safety, and privacy in the AI or data 
science curriculum. The council has also highlighted the cyber security related to AI and 
emphasized on establishing responsible strategies and plans at a federal level, including R&D 
for the sustainable security system development and operation in response to cyberattacks.
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Fig. 1. Research and development strategic plan of artificial intelligence.60 
AI = artificial intelligence.
The present health care system assumes that all responsibility lies in the hands of the medical 
staff in the event of a medical accident. The AI-based medical technology may affect the 
judgment of physicians in various areas and may sometimes cause negative impacts, resulting 
in medical accidents. In such cases, liability issues would arise, and in the current health care 
system, it is highly likely that the medical institution or physicians who ultimately introduced 
the AI-based medical technology would be responsible for the case. Hence, physicians need 
to learn how to better utilize and interpret AI algorithms and be aware of potential legal 
consequences associated with AI use in medical practice.61 In addition, efforts in academia 
and policymaking should be made to straighten the liability issues and to evaluate the 
medical accident risks based on the various characteristics of AI technologies.62 Specifically, 
new policies should be introduced for the establishment and operation of the AI monitoring 
centers in medical institutions and a national level safety monitoring center for monitoring 
the safety of the AI-based medical technologies. In addition, a system for measuring the 
liability and strengthening the awareness of patients and medical staff on medical accidents 
that may take place when applying the AI-based medical technologies should be established.
Balanced application with existing health care systems
Applying a newly developed AI technology to real-world health care service can lead to 
unexpected problems. Therefore, the introduction of AI devices should be in harmony 
with existing health care systems, and the performance of AI devices must be monitored 
periodically. It is also important that AI devices should be easy to use and familiar to medical 
staff and patients to avoid any misunderstandings and errors when making medical decisions.
As the AI technology in its nature mainly relies on data, performance changes may be found 
when the pre-applied AI technology is retrained with the desired field data. This change 
may not always result in a performance improvement; rather it may result in a performance 
degradation.63 In addition, the AI device performances may vary when the distribution 
or severity of patients in the institution changes depending on the differences in social, 
economic, and medical environments. Although the current laws and regulations in Korea 
do not allow the use of field data in improving the AI device performances, considering 
the nature of the technology, retraining using field data could be approved in the near 
future provided certain conditions are fulfilled. Accordingly, the performance of AI devices 
should be periodically checked even after the clinical application to prevent any unexpected 
performance degradation or malfunction.
Considering the importance and complexity of the modern health care field, the AI technology 
should be applied to health care as naturally and seamlessly as possible without causing 
excessive changes in the current medical practices. For this reason, it is necessary to implement 
the interaction and interface technologies that can enable the medical staff to apply AI 
technology to the medical field in a natural way even if they do not directly understand the 
technical aspects of the AI devices. These technologies can be implemented in the form of 
conversational AI, voice recognition, real-time recommendation, monitoring, and various 
visual overlay technologies. At the same time, careful considerations should be given to these 
user interface elements when developing and integrating AI technologies into health care.
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CONCLUSIONS
AI technologies are expected to bring innovations to the existing medical technologies 
and future health care. The currently available AI-based health care technologies have 
shown outstanding results in accurately diagnosing and classifying patient conditions and 
predicting the course of diseases by using the accumulated medical data. Accordingly, 
these technologies are expected to bring contributions in assisting the medical staff in the 
treatment decision-making and in the process improving the treatment results. However, 
AI-based health care technologies currently have various issues regarding privacy, reliability, 
safety, and liability. For the AI technologies to be more actively applied in health care, 
general public awareness of AI, establishment of standardized guidelines, and systematic 
improvements will be required in the future in addition to the technological advancements.
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